Search
Descriptor English: Tumor Escape
Descriptor Spanish: Escape del Tumor
Descriptor escape del tumor
Entry term(s) escape inmune tumoral
evasión inmune tumoral
evasión inmunitaria del tumor
Scope note: Capacidad de los tumores para eludir su destrucción por el SISTEMA INMUNITARIO. Las teorías acerca de los posibles mecanismos por los que esto ocurre están relacionadas tanto con la INMUNIDAD CELULAR como con la inmunidad humoral (FORMACIÓN DE ANTICUERPOS), así como también con las vías coestimuladoras vinculadas a los ANTÍGENOS CD28 y al ANTÍGENO B7-1.
Descriptor Portuguese: Evasão Tumoral
Descriptor French: Échappement de la tumeur à la surveillance immunitaire
Entry term(s): Evasion, Tumor Immune
Evasions, Tumor Immune
Immune Escape, Tumor
Immune Evasion, Tumor
Immune Evasions, Tumor
Tumor Immune Escape
Tumor Immune Evasion
Tumor Immune Evasions
Tree number(s): G12.900
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D019139
Scope note: The ability of tumors to evade destruction by the IMMUNE SYSTEM. Theories concerning possible mechanisms by which this takes place involve both cellular immunity (IMMUNITY, CELLULAR) and humoral immunity (ANTIBODY FORMATION), and also costimulatory pathways related to CD28 ANTIGENS and B7-1 ANTIGEN.
Annotation: entry term IMMUNE EVASION, TUMOR: IMMUNE EVASION is also available
Allowable Qualifiers: DE drug effects
ES ethics
GE genetics
IM immunology
PH physiology
RE radiation effects
Public MeSH Note: 96
History Note: 96
Related: Antigenic Modulation MeSH
Immune Tolerance MeSH
DeCS ID: 32587
Unique ID: D019139
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1996/01/01
Date of Entry: 1995/06/05
Revision Date: 2020/02/05
Tumor Escape - Preferred
Concept UI M0028536
Scope note The ability of tumors to evade destruction by the IMMUNE SYSTEM. Theories concerning possible mechanisms by which this takes place involve both cellular immunity (IMMUNITY, CELLULAR) and humoral immunity (ANTIBODY FORMATION), and also costimulatory pathways related to CD28 ANTIGENS and B7-1 ANTIGEN.
Preferred term Tumor Escape
Entry term(s) Evasion, Tumor Immune
Evasions, Tumor Immune
Immune Escape, Tumor
Immune Evasion, Tumor
Immune Evasions, Tumor
Tumor Immune Escape
Tumor Immune Evasion
Tumor Immune Evasions



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey